Bioxcel therapeutics to report second quarter 2021 financial results on august 10, 2021

New haven, conn., july 28, 2021 (globe newswire) -- bioxcel therapeutics, inc. (“bioxcel” or the “company”) (nasdaq: btai), a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, today announced it will release its second quarter 2021 financial results on tuesday, august 10, 2021 before the open of the u.s. financial markets. bioxcel's management team will also host a conference call and webcast at 8:30 am edt to discuss the company's financial results and to provide a general business update.
BTAI Ratings Summary
BTAI Quant Ranking